Latest news and events

A scientific dispute spanning six decades about fundamental mechanisms of visual perception in mammals has now been settled. Researchers at TUM have succeeded in observing the visual information flow from neuron to neuron. Their findings confirm the validity of the 1981 Nobel Prize-winning model by… [read more]

A significant step toward the potential prevention of stomach cancer: Researchers at the Technical University of Munich (TUM) have increased the effectiveness of a standard antibiotic by a factor of 60 through targeted chemical modifications. In laboratory and animal studies, the new drug candidate… [read more]

Custom-designed proteins that can control cells and activate them in a targeted way: Thomas Schlichthärle wants to use them to advance the development of new medicines. In this new episode of “NewIn,” he explains how researchers in other disciplines can benefit from his methods. [read more]

Genetically modified immune cells can offer precious additional time to patients with advanced multiple myeloma. However, these therapies lose their impact as the molecules on cancer cells that immune cells recognize gradually vanish. Researchers at the Technical University of Munich (TUM) have now… [read more]

Whether in the gut, mouth, or on the skin, the human body is colonized by bacteria. Most of them are beneficial and we find distinct microbial communities at different body sites. A team led by the Technical University of Munich (TUM) and King’s College London has now found strong evidence that… [read more]

Prof. Julia Steinhoff-Wagner and Prof. Friederike Ebner have been appointed as independent experts to the commissions for animal feed and animal nutrition and to the Bf3R commission, respectively. [read more]

How can the properties of slime molds help improve artificial organs? Why does pancreatic cancer form synapses? How can nuclear magnetic resonance measurements become more sensitive? Six research teams at the Technical University of Munich (TUM) aim to answer these and other questions with support… [read more]

Why do nerve cells die in dementia - and can this process be slowed down? Researchers from the Technical University of Munich (TUM), the LMU Clinic and Helmholtz Munich have shown that the cell death program ferroptosis can trigger neurodegeneration in the human brain. At the same time, however,… [read more]

Patients receiving intensive cancer treatments often suffer from severe damage to the intestinal lining. Researchers from the Technical University of Munich (TUM) and the Leibniz Institute for Immunotherapy (LIT) have discovered that certain immune cells can trigger healing processes. They use… [read more]

Pancreatic cancer is one of the deadliest types of tumors. A team at the Technical University of Munich (TUM) has discovered that pancreatic tumors exploit the body’s nervous system by forming so-called pseudosynapses. Through a specific receptor, the cancer cells take up the neurotransmitter… [read more]

It is well established that gut microbiome composition plays a pivotal role in human health – yet the precise connections are still not fully elucidated. Researchers at the Technical University of Munich (TUM) have moved a step closer to understanding these complex interactions: they have identified… [read more]

TherVacB, a therapeutic vaccine for chronic hepatitis B, has entered its first clinical trial in patients. The first patient was enrolled in June 2025 and treated with the vaccine. In a previous trial in healthy volunteers, the vaccine demonstrated a favorable safety profile and triggered the… [read more]

Food security, public health and animal welfare: the ImmunoChick 2.0 project is working on key issues of our time. The research team, led by Freie Universität Berlin and with the participation of TUM, is investigating immune defence in chickens, based on a kind that isunique in the world. The German… [read more]

A new connectomics research center will be established on the TUM campus in Garching, which will focus on the comprehensive mapping and analysis of all neuronal connections in the brain. At the Center for Structural and Functional Connectomics (CSFC) at the Technical University of Munich (TUM),… [read more]

Biophysicist and organoid researcher Andreas Bausch is taking over the Heinz Nixdorf Foundation Professorship at the Technical University of Munich (TUM). This comes with over 2.3 million euros in research funding. In addition, the equipment for a research laboratory in TUM's future Center for… [read more]